Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Neurology

Journal Scan / Research · November 27, 2024

Neurologic Outcomes in People With MS Treated With Immune Checkpoint Inhibitors for Oncologic Indications

Neurology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Neurology
Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic Indications
Neurology 2024 Dec 10;103(11)e210003, CM Quinn, P Rajarajan, AJ Gill, H Kopinsky, AB Wolf, CS de Camargo, J Lamb, TE Bacon, JC Murray, JC Probasco, KM Galetta, D Kantor, P Coyle, V Bhise, E Alvarez, SE Conway, S Bhattacharyya, I Kister

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading